Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).
- Status
- COMPLETED
- Phase
- PHASE2
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma
- Status
- COMPLETED
- Phase
- NA
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE1
Symptom Management for YA Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ATL001 in Patients With Metastatic or Recurrent Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
- Status
- WITHDRAWN
- Phase
- N/A
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PDR001 + Panobinostat for Melanoma and NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection
- Status
- COMPLETED
- Phase
- PHASE1
Risk Information and Skin-cancer Education for Undergraduate Prevention
- Status
- COMPLETED
- Phase
- NA